Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02312351/Upper-Limb-Muscle-Spasticity-Global-Clinical-Trials-Review-H2-2014.html

Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Upper Limb Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Upper Limb Muscle Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Upper Limb Muscle Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Upper Limb Muscle Spasticity 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Upper Limb Muscle Spasticity Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Merz Pharma GmbH & Co. KgaA 28
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 28
Ipsen S.A. 29
Clinical Trial Overview of Ipsen S.A. 29
Allergan, Inc. 30
Clinical Trial Overview of Allergan, Inc. 30
Medy-Tox Inc. 31
Clinical Trial Overview of Medy-Tox Inc. 31
Hugel Pharma Co. Ltd. 32
Clinical Trial Overview of Hugel Pharma Co. Ltd. 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Daewoong Co., Ltd. 34
Clinical Trial Overview of Daewoong Co., Ltd. 34
ASIS Corporation 35
Clinical Trial Overview of ASIS Corporation 35
Clinical Trial Overview of Top Institutes / Government 36
University College London 36
Clinical Trial Overview of University College London 36
Mount Sinai Hospital 37
Clinical Trial Overview of Mount Sinai Hospital 37
Five Key Clinical Profiles 38
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74

List of Tables
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Region, 2014* 6
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Upper Limb Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 28
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 29
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 30
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014* 31
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Hugel Pharma Co. Ltd., 2014* 32
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Daewoong Co., Ltd., 2014* 34
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by ASIS Corporation, 2014* 35
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2014* 36
Upper Limb Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014* 37

List of Figures
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Upper Limb Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 73


To order this report: Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02312351/Upper-Limb-Muscle-Spasticity-Global-Clinical-Trials-Review-H2-2014.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker